GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirnaomics Ltd (HKSE:02257) » Definitions » Net Margin %

Sirnaomics (HKSE:02257) Net Margin % : -580.32% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sirnaomics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Sirnaomics's Net Income for the six months ended in Dec. 2024 was HK$-80.21 Mil. Sirnaomics's Revenue for the six months ended in Dec. 2024 was HK$13.82 Mil. Therefore, Sirnaomics's net margin for the quarter that ended in Dec. 2024 was -580.32%.

The historical rank and industry rank for Sirnaomics's Net Margin % or its related term are showing as below:

HKSE:02257' s Net Margin % Range Over the Past 10 Years
Min: -2900.83   Med: -2889.96   Max: -2889.96
Current: -2900.83


HKSE:02257's Net Margin % is ranked worse than
84.12% of 995 companies
in the Biotechnology industry
Industry Median: -114.45 vs HKSE:02257: -2900.83

Sirnaomics Net Margin % Historical Data

The historical data trend for Sirnaomics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirnaomics Net Margin % Chart

Sirnaomics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial - - - - -2,889.96

Sirnaomics Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -580.32

Competitive Comparison of Sirnaomics's Net Margin %

For the Biotechnology subindustry, Sirnaomics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirnaomics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirnaomics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sirnaomics's Net Margin % falls into.


;
;

Sirnaomics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sirnaomics's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-399.421/13.821
=-2,889.96 %

Sirnaomics's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-80.206/13.821
=-580.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sirnaomics  (HKSE:02257) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Sirnaomics Net Margin % Related Terms

Thank you for viewing the detailed overview of Sirnaomics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirnaomics Business Description

Traded in Other Exchanges
Address
No.218 Xinghu Street, Unit 415, A4 Building, Suzhou Industrial Park, Suzhou, CHN
Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China.
Executives
Poon Hung Fai 2101 Beneficial owner
Lu Yang 2101 Beneficial owner
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Dai Xiaochang 2201 Interest of corporation controlled by you
Yan Xia Ling 2202 Interest of your spouse
Ceng Yu 2201 Interest of corporation controlled by you
Li Jie 2201 Interest of corporation controlled by you
Li Lele 2202 Interest of your spouse
Shanghai Chongshi Enterprise Management Partnership(lp) 2101 Beneficial owner
Shenzhen Qianhai Rotating Boulder Fund Management Co.,ltd 2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Second Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Third Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you

Sirnaomics Headlines

No Headlines